Targeted Therapy
The management of lung cancer has been transformed by the advent of next generation sequencing leading to identification of therapeutic targets resulting in better clinical outcomes compared to patients with absence of molecular targets. [9] Therefore molecular testing for treatable oncogenic alterations should be implemented as an essential part of diagnostic testing before deciding treatment plan for a patient with newly diagnosed NSCLC.[22,23]